Moderate riskFDA DeviceClass II

Diowave 250W laser system needs software update for power output correction

Diowave 250W infrared laser systems used for temporary muscle and joint pain relief are operating at a maximum power output of 70W, which exceeds the FDA-cleared limit of 60W. A software update is required to correct the power output to the approved level.

From the FDA notice · Read the official notice ↗

What to do

  1. Contact Technological Medical Advancements LLC if you own or operate a Diowave 250W laser system
  2. Update your system software to version V1.81 or later
  3. Do not use the device until the software update is applied

Is yours affected?

Compare your label or packaging with the recalled product.

Product
Diowave Laser System, REF: Diowave 250W
Sold in
Nationwide
Made for
Adults (0 months and older)

Details

Units affected
16
Illnesses reported
None reported
Manufactured in
1601 Belvedere Rd Ste E-180, West Palm Beach, FL, United States
Classification
Class II
Recall number
Z-2162-2026

In the FDA's words

Description
Diowave Laser System, REF: Diowave 250W Software update is needed for laser systems, for topical infrared heating to provide temporary relief of minor muscle and joint pain, spasms, stiffness associated with minor arthritis, and to temporarily increase local blood circulation, operating at a maximum average power output of 70W, which is beyond the FDA cleared 60W. UDI-DI: G180DIOWAVESTEALTHMAX0. All software versions prior to, but not including V1.81 Distribution: US Nationwide distribution in the states of TX, CA, MI, MD, PA, FL, MN, DC, MI. Affected quantity: 16
Hazard
Software update is needed for laser systems, for topical infrared heating to provide temporary relief of minor muscle and joint pain, spasms, stiffness associated with minor arthritis, and to temporarily increase local blood circulation, operating at a maximum average power output of 70W, which is beyond the FDA cleared 60W.

Related topics